Charlotte's Web co-founder Jared Stanley steps down from board to lead DeFloria

Co-founder Jared Stanley resigned from Charlotte's Web's Board of Directors effective June 3, 2026, to focus full-time on his role as CEO of DeFloria, a clinical-stage botanical pharmaceutical company co-founded by Charlotte's Web developing a treatment for autism-related irritability. The move is supported by management and allows Stanley to concentrate on advancing DeFloria's FDA Phase 2 program while maintaining advisory connections to Charlotte's Web.